185 related articles for article (PubMed ID: 28360223)
1. Risk stratification based on screening history: the NELSON lung cancer screening study.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Walter J; Nackaerts K; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Sep; 72(9):819-824. PubMed ID: 28360223
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
3. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H
Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
[TBL] [Abstract][Full Text] [Related]
4. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
[TBL] [Abstract][Full Text] [Related]
6. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
van Iersel CA; de Koning HJ; Draisma G; Mali WP; Scholten ET; Nackaerts K; Prokop M; Habbema JD; Oudkerk M; van Klaveren RJ
Int J Cancer; 2007 Feb; 120(4):868-74. PubMed ID: 17131307
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.
van den Bergh KA; Essink-Bot ML; Borsboom GJ; Scholten ET; van Klaveren RJ; de Koning HJ
Eur Respir J; 2011 Jul; 38(1):154-61. PubMed ID: 21148229
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
[TBL] [Abstract][Full Text] [Related]
9. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
11. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ; van der Aalst CM; de Jong PA; Scholten ET; Nackaerts K; Heuvelmans MA; Lammers JJ; Weenink C; Yousaf-Khan U; Horeweg N; van 't Westeinde S; Prokop M; Mali WP; Mohamed Hoesein FAA; van Ooijen PMA; Aerts JGJV; den Bakker MA; Thunnissen E; Verschakelen J; Vliegenthart R; Walter JE; Ten Haaf K; Groen HJM; Oudkerk M
N Engl J Med; 2020 Feb; 382(6):503-513. PubMed ID: 31995683
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial.
van der Aalst CM; van den Bergh KA; Willemsen MC; de Koning HJ; van Klaveren RJ
Thorax; 2010 Jul; 65(7):600-5. PubMed ID: 20627916
[TBL] [Abstract][Full Text] [Related]
13. Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial.
van der Aalst CM; de Koning HJ
Lung Cancer; 2016 Apr; 94():96-101. PubMed ID: 26973213
[TBL] [Abstract][Full Text] [Related]
14. Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
van der Aalst CM; van Iersel CA; van Klaveren RJ; Frenken FJ; Fracheboud J; Otto SJ; de Jong PA; Oudkerk M; de Koning HJ
Lung Cancer; 2012 Jul; 77(1):51-7. PubMed ID: 22459203
[TBL] [Abstract][Full Text] [Related]
15. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme.
Ashraf H; Saghir Z; Dirksen A; Pedersen JH; Thomsen LH; Døssing M; Tønnesen P
Thorax; 2014 Jun; 69(6):574-9. PubMed ID: 24443174
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
[TBL] [Abstract][Full Text] [Related]
17. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
[TBL] [Abstract][Full Text] [Related]
18. The impact of a lung cancer computed tomography screening result on smoking abstinence.
van der Aalst CM; van Klaveren RJ; van den Bergh KA; Willemsen MC; de Koning HJ
Eur Respir J; 2011 Jun; 37(6):1466-73. PubMed ID: 21148233
[TBL] [Abstract][Full Text] [Related]
19. Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study.
Yousaf-Khan U; Horeweg N; van der Aalst C; Ten Haaf K; Oudkerk M; de Koning H
J Thorac Oncol; 2015 May; 10(5):747-753. PubMed ID: 25664626
[TBL] [Abstract][Full Text] [Related]
20. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
